Influence of Pulmonary Valve Function Preservation Technique for Tetralogy of Fallot Repair on Right Ventricular Performance in Children
Keywords:Fallot Tetralogy repair, RV dysfunction, myocardial performance index
Background: Right ventricular (RV) ejection fraction may remain normal or even high despite significant impairment of RV myocardial performance in cases of total repair for tetralogy of Fallot (TOF). The aim of this study is to evaluate the influence of pulmonary valve function preservation (PVFP) versus monocuspid transannular patch augmentation (MTAPA) surgical strategies for Fallot repair on postoperative RV performance.
Methods: This retrospective study enrolled all patients
(N = 480) who had TOF repaired at our center over a period of 7 years (March 2012 to January 2019). Group I included 377 patients (78.5%) who underwent TOF repair with MTAPA, and group II included 103 patients (21.5%) who underwent TOF repair with PVFP, which included all patients with pulmonary valve sparing with limited sub- or supravalvular patch. Patients’ preoperative and postoperative echocardiography and other parameters (ventilation time, intensive care unit [ICU] stay duration, and RV myocardial performance index [RVMPI]) were recorded to evaluate RV function.
Results: We observed a significant statistical difference in the postoperative course between groups I and II, with excellent midterm outcomes for group II. A remarkable significant improvement of RVMPI took place in group II versus group I (P < .0001), as well as a significant decline in pulmonary regurgitation progression (P < .0001). The immediate postoperative RVMPI in group I (0.79 ± 0.63) versus that in group II (0.36 ± 0.17) was significantly higher (P < .0001), as was the late postoperative RVMPI (group I, 0.64 ± 0.25; group II, 0.49 ± 0.17; P < 0001). The postoperative RV outflow tract was decreased in group II versus group I. Group II had a significantly shorter duration on mechanical ventilation and in the ICU and less need for inotropes.
Conclusion: We conclude that TOF repair patients have excellent RV myocardial performance with the PVFP surgical strategy in comparison with MTAPA.
Awori MN, Leong W, Artrip JH, O’Donnell C. 2013. Tetralogy of Fallot repair: Optimal z-score use for transannular patch insertion. Eur J Cardio-Thorac Surg 43:483-486.
Bacha EA, Scheule AM, Zurakowski D, et al. 2001. Long-term results after early primary repair of tetralogy of Fallot. J Thorac Cardiovasc Surg 122:154-161.
Bonnemains L, Stos B, Vaugrenard T, Marie PY, Odille F, Boudjemline Y. 2012. Echocardiographic right ventricle longitudinal contraction indices cannot predict ejection fraction in post-operative Fallot children. Eur Heart J Cardiovasc Imaging 13:235-242.
Carminati M, Pluchinotta FR, Piazza L, et al. 2015. Echocardiographic assessment after surgical repair of tetralogy of fallot. Front Pediatr 3:3.
Eidem BW, O’Leary PW, Tei C, Seward JB. 2000. Usefulness of the myocardial performance index for assessing right ventricular function in congenital heart disease. Am J Cardiol 86:654-658
Frigiola A, Redington AN, Cullen S, Vogel M. 2004. Pulmonary regurgitation is an important determinant of right ventricular contractile dysfunction in patients with surgically repaired tetralogy of Fallot. Circulation 110(suppl 2):153-157.
Gatzoulis MA, Balaji S, Webber SA, et al. 2000. Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: A multicentre study. Lancet 356:975-981.
Geva T, Sandweiss BM, Gauvreau K, Lock JE, Powell AJ. 2004. Factors associated with impaired clinical status in long-term survivors of tetralogy of Fallot repair evaluated by magnetic resonance imaging. J Am Coll Cardiol 43:1068-1074.
Grignola JC, Ginés F and Guzzo D. 2006. Comparison of the Tei index with invasive measurements of right ventricular function. Int J Cardiol 113:25-33.
Helbing WA, Niezen RA, Le Cessie S, et al. 1996. Right ventricular diastolic function in children with pulmonary regurgitation after repair of tetralogy of Fallot: Volumetric evaluation by magnetic resonance velocity mapping. J Am Coll Cardiol 28:1827-1835.
Karl TR, Sano S, Pornviliwan S, Mee RBB. 1992. Tetralogy of Fallot: Favorable outcome of nonneonatal transatrial, transpulmonary repair. Ann Thorac Surg 54:903-907.
Kirklin JW, Blackstone EH, Jonas RA, et al. 1992. Morphologic and surgical determinants of outcome events after repair of tetralogy of Fallot and pulmonary stenosis: A two-institutional study. J Thorac Cardiovasc Surg 103:706-723.
Koestenberger M, Nagel B, Avian A, et al. 2012. Systolic right ventricular function in children and young adults with pulmonary artery hypertension secondary to congenital heart disease and tetralogy of Fallot: Tricuspid annular plane systolic excursion (TAPSE) and magnetic resonance imaging data. Congenit Heart Dis 7:250-258.
Lee N, Taylor MD, Banerjee RK. 2015. Right ventricle-pulmonary circulation dysfunction: A review of energy-based approach. Biomed Eng Online 14(suppl 1):S8.
Lozano-Balseiro M, Garcia-Vieites M, Martínez-Bendayán I, et al. 2019. Valve-sparing tetralogy of Fallot repair with intraoperative dilation of the pulmonary valve. Mid-term results. Semin Thorac Cardiovasc Surg 31:828-834.
Mahran Y, Schueler R, Weber M, et al. 2016. Noninvasive model including right ventricular speckle tracking for the evaluation of pulmonary hypertension. World J Cardiol 8:472-480.
Puchalski MD, Williams RV, Askovich B, Minich LL, Mart C, Tani LY. 2007. Assessment of right ventricular size and function: Echo versus magnetic resonance imaging. Congenit Heart Dis 2:27-31.
Rebergen SA, Chin JGJ, Ottenkamp J, Van der Wall EE, de Roos A. 1993. Pulmonary regurgitation in the late postoperative follow-up of tetralogy of Fallot: Volumetric quantification by MR velocity mapping. Circulation 88(pt 1):2257-2266.
Roberson DA, Cui W. 2007. Right ventricular Tei index in children: Effect of method, age, body surface area, and heart rate. J Am Soc Echocardiogr 20:764-770.
Rudski LG, Lai WW, Afilalo J, et al. 2010. Guidelines for the echocardiographic assessment of the right heart in adult: A report from the American Society of Echocardiography. J Am Soc Echocardiogr 23:700-701.
Schwerzmann M, Samman AM, Salehian O, et al. 2007. Comparison of echocardiographic and cardiac magnetic resonance imaging for assessing right ventricular function in adults with repaired tetralogy of Fallot. Am J Cardiol 99:1593-1597.
Selly JB, Iriart X, Roubertie F, et al. 2015. Multivariable assessment of the right ventricle by echocardiography in patients with repaired tetralogy of Fallot undergoing pulmonary valve replacement: A comparative study with magnetic resonance imaging. Arch Cardiovasc Dis 108:5-15.
Singh GK, Greenberg SB, Yap YS, Delany DP, Keeton BR, Monro JL. 1998. Right ventricular function and exercise performance late after primary repair of tetralogy of Fallot with the transannular patch in infancy. Am J Cardiol 81:1378-1382.
Song B, Qi Q, Liu R, Xing W, Tang H, Li Y. 2015. Clinical value of Tei index in pediatric patients with repaired tetralogy of Fallot. Int J Clin Exp Med 8:7971-7976.
Su HM, Lin TH, Voon WC, Lee KT, Chu CS, Yen HW, Lai WT, Sheu SH. 2007. Correlation of Tei index obtained from tissue Doppler echocardiography with invasive measurements of left ventricular performance. Echocardiography 24:252-257.
Suzuki J-I, Chang J-M, Caputo GR, Higgins CB. 1991. Evaluation of right ventricular early diastolic filling by cine nuclear magnetic resonance imaging in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 18:120-126.
Tei C, Dujardin KS, Hodge DO, et al. 1996. Doppler echocardiographic index for assessment of global right ventricular function. J Am Soc Echocardiogr 9:838-847.
Tei C, Dujardin KS, Hodge DO, Kyle RA, Tajik JA, Seward JB. 1996. Doppler index combining systolic and diastolic myocardial performance: Clinical value in cardiac amyloidisis. J Am Coll Cardiol 28:658-664.
Weidemann F, Eyskens B, Mertens L, et al. 2002. Quantification of regional right and left ventricular function by ultrasonic strain rate and strain indexes after surgical repair of tetralogy of Fallot. Am J Cardiol 90:133-138.
Yoo BW, Kim JO, Kim YJ, Choi JY, Park HK, Park YH, Sul JH. 2012. Impact of pressure load caused by right venricular outflow tract obstruction on right ventricular volume overload in patients with repaired tetralogy of Fallot. J Thorac Cardiovasc Surg 143:1299-1304.
How to Cite
Author Disclosure & Copyright Transfer Agreement
In order to publish the original work of another person(s), The Heart Surgery Forum® must receive an acknowledgment of the Author Agreement and Copyright Transfer Statement transferring to Forum Multimedia Publishing, L.L.C., a subsidiary of Carden Jennings Publishing Co., Ltd. the exclusive rights to print and distribute the author(s) work in all media forms. Failure to check Copyright Transfer agreement box below will delay publication of the manuscript.
A current form follows:
The author(s) hereby transfer(s), assign(s), or otherwise convey(s) all copyright ownership of the manuscript submitted to Forum Multimedia Publishing, LLC (Publisher). The copyright transfer covers the exclusive rights to reproduce and distribute the article and the material contained therein throughout the world in all languages and in all media of expression now known or later developed, including but not limited to reprints, photographic reproduction, microfilm, electronic data processing (including programming, storage, and transmission to other electronic data record(s), or any other reproductions of similar nature), and translations.
However, Publisher grants back to the author(s) the following:
- The right to make and distribute copies of all or part of this work for use of the author(s) in teaching;
- The right to use, after publication in The Heart Surgery Forum, all or part of the material from this work in a book by the author(s), or in a collection of work by the author(s);
- The royalty-free right to make copies of this work for internal distribution within the institution/company that employs the author(s) subject to the provisions below for a work-made-for-hire;
- The right to use figures and tables from this work, and up to 250 words of text, for any purpose;
- The right to make oral presentations of material from this work.
Publisher reserves the right to grant or refuse permission to third parties to republish all or part of the article or translations thereof. To republish, such third parties must obtain written permission from the Publisher. (This is in accordance with the Copyright Statute, United States Code, Title 17. Exception: If all authors were bona fide officers or employees of the U.S. Government at the time the paper was prepared, the work is a “work of the US Government” (prepared by an officer or employee of the US Government as part of official duties), and therefore is not subject to US copyright; such exception should be indicated on signature lines. If this work was prepared under US Government contract or grant, the US Government may reproduce, royalty-free, all or portions of this work and may authorize others to do so, for official US Government purposes only, if the US Government contract or grant so requires.
I have participated in the conception and design of this work and in the writing of the manuscript and take public responsibility for it. Neither this manuscript nor one with substantially similar content under my authorship has been published, has been submitted for publication elsewhere, or will be submitted for publication elsewhere while under consideration by The Heart Surgery Forum, except as described in an attachment. I have reviewed this manuscript (original version) and approve its submission. If I am listed above as corresponding author, I will provide all authors with information regarding this manuscript and will obtain their approval before submitting any revision. I attest to the validity, accuracy, and legitimacy of the content of the manuscript and understand that Publisher assumes no responsibility for the validity, accuracy, and legitimacy of its content. I warrant that this manuscript is original with me and that I have full power to make this Agreement. I warrant that it contains no matter that is libelous or otherwise unlawful or that invades individual privacy or infringes any copyright or other proprietary right. I agree to indemnify and hold Publisher harmless of and from any claim made against Publisher that relates to or arises out of the publication of the manuscript and agree that this indemnification shall include payment of all costs and expenses relating to the defense of any such claim, including all reasonable attorney’s fees.
I warrant that I have no financial interest in the drugs, devices, or procedures described in the manuscript (except as disclosed in the attached statement).
I state that the institutional Human Subjects Committee and/or the Ethics Committee approved the clinical protocol reported in this manuscript for the use of experimental techniques, drugs, or devices in human subjects and appropriate informed consent documents were utilized.
Furthermore, I state that any and all animals used for experimental purposes received humane care in USDA registered facilities in compliance with the “Principles of Laboratory Animal Care” formulated by the National Society for Medical Research and the “Guide for the Care and Use of Laboratory Animals” prepared by the Institute of Laboratory Animal Resources and published by the National Institutes of Health (NIH Publication No. 85-23, revised 1985).